ArticleNaunyn-Schmiedeberg's archives of pharmacology2023

Dapagliflozin protects against dilated cardiomyopathy progression by targeting NLRP3 inflammasome activation.

Jiaxin Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.